Dr. Gaurav Gulati has done B. Pharmacy, MS Pharmacology and Ph.D. in Pharmaceutical Sciences. As a Ph.D. graduate, he developed polymeric nanoformulations for sustained release of anti-tuberculosis drugs. Read More.
Loren Kinman, MS has been with the University of Washington since 1996. He is the author, along with Rodney Ho, of several early seminal works on lipid-drug association and targeting of HIV protease inhibitors to the lymphoid tissues. Read More.
Josefin Koehn, MS has worked for four years as a research scientist in Dr. Rodney Ho’s lab, a recognized entrepreneur and expert in the field of nanoparticle-based drug delivery, where she has concentrated on the analytical studies of HIV drugs. Read More.
Sarah Lane recently joined Dr. Rodney Ho’s lab as a research scientist. She graduated from Loyola University Chicago with a degree in biology, and has since gained an array of experience in the sciences. Read More.
Dr. Lisa McConnachie is a research scientist and laboratory manager for Rodney Ho. She received her PhD in Pharmaceutics from the University of Washington in 2002 with Dr. Ho as her advisor. Read More.
Ken Tapia, MS is a master’s-level biostatistician with the Center for AIDS Research (CFAR) at the University of Washington, working under Dr. Sarah Holte to provide statistical support to collaborating investigators. Read More.